Related references
Note: Only part of the references are listed.The Mechanism of Flecainide Action in CPVT Does Not Involve a Direct Effect on RyR2
Mark L. Bannister et al.
CIRCULATION RESEARCH (2015)
Efficacy of Different Beta-Blockers in the Treatment of Long QT Syndrome
Abeer Abu-Zeitone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Yield of Molecular and Clinical Testing for Arrhythmia Syndromes Report of 15 Years' Experience
Nynke Hofman et al.
CIRCULATION (2013)
Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes
Silvia G. Priori et al.
EUROPACE (2013)
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death
Connie R. Bezzina et al.
NATURE GENETICS (2013)
Mutations in Calmodulin Cause Ventricular Tachycardia and Sudden Cardiac Death
Mette Nyegaard et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Mutations in Cytoplasmic Loops of the KCNQ1 Channel and the Risk of Life-Threatening Events Implications for Mutation-Specific Response to β-Blocker Therapy in Type 1 Long-QT Syndrome
Alon Barsheshet et al.
CIRCULATION (2012)
Seasonal and Circadian Distributions of Cardiac Events in Genotyped Patients With Congenital Long QT Syndrome
Masateru Takigawa et al.
CIRCULATION JOURNAL (2012)
Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia Disease Penetrance and Expression in Cardiac Ryanodine Receptor Mutation-Carrying Relatives
Christian van der Werf et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2012)
Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments
Christian van der Werf et al.
EUROPACE (2012)
Atrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation
Hany Dimitri et al.
HEART RHYTHM (2012)
Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human
Nathalie Roux-Buisson et al.
HUMAN MOLECULAR GENETICS (2012)
Spectrum and Prevalence of Mutations Involving BrS1-Through BrS12-Susceptibility Genes in a Cohort of Unrelated Patients Referred for Brugada Syndrome Genetic Testing Implications for Genetic Testing
Lia Crotti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Not All Beta-Blockers Are Equal in the Management of Long QT Syndrome Types 1 and 2
Priya Chockalingam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Cardiac Channel Molecular Autopsy: Insights From 173 Consecutive Cases of Autopsy-Negative Sudden Unexplained Death Referred for Postmortem Genetic Testing
David J. Tester et al.
MAYO CLINIC PROCEEDINGS (2012)
QTc Behavior During Exercise and Genetic Testing for the Long-QT Syndrome
Peter J. Schwartz et al.
CIRCULATION (2011)
Electrophysiologic basis for the antiarrhythmic actions of ranolazine
Charles Antzelevitch et al.
HEART RHYTHM (2011)
Mutation and gender-specific risk in type 2 long QT syndrome: Implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome
Dimitry Migdalovich et al.
HEART RHYTHM (2011)
Electrophysiologic testing predicts events in Brugada syndrome patients
Josep Brugada et al.
HEART RHYTHM (2011)
Rebuttal to EP testing predicts cardiac events in patients with Brugada syndrome
Arthur A. M. Wilde et al.
HEART RHYTHM (2011)
Flecainide Therapy Reduces Exercise-Induced Ventricular Arrhythmias in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
Christian van der Werf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome Results From the FINGER Brugada Syndrome Registry
V. Probst et al.
CIRCULATION (2010)
Short QT Syndrome: From Bench to Bedside
Chinmay Patel et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2010)
An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing
Jamie D. Kapplinger et al.
HEART RHYTHM (2010)
Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia
Meiso Hayashi et al.
CIRCULATION (2009)
Prevalence of the Congenital Long-QT Syndrome
Peter J. Schwartz et al.
CIRCULATION (2009)
Drugs and Brugada syndrome patients: Review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)
Pieter G. Postema et al.
HEART RHYTHM (2009)
Genotype-Phenotype Aspects of Type 2 Long QT Syndrome
Wataru Shimizu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
Hiroshi Watanabe et al.
NATURE MEDICINE (2009)
Fever increases the risk for cardiac arrest in the Brugada syndrome
Ahmad S. Amin et al.
ANNALS OF INTERNAL MEDICINE (2008)
Fragmented QRS as a Marker of Conduction Abnormality and a Predictor of Prognosis of Brugada Syndrome
Hiroshi Morita et al.
CIRCULATION (2008)
Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome
Masateru Takigawa et al.
HEART RHYTHM (2008)
Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia
Arthur A. M. Wilde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cardiac sodium channel overlap syndromes: Different faces of SCN5A mutations
Carol Ann Remme et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2008)
Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients
Yanfei Ruan et al.
CIRCULATION (2007)
Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia
Uwais Mohamed et al.
HEART RHYTHM (2006)
Short QT syndrome: clinical findings and diagnostic-therapeutic implications
Carla Giustetto et al.
EUROPEAN HEART JOURNAL (2006)
Risk stratification of individuals with the Brugada electrocardiogram: A meta-analysis
Anil K. Gehi et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2006)
Effect of clinical phenotype on yield of long QT syndrome genetic testing
DJ Tester et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene
SG Priori et al.
CIRCULATION RESEARCH (2005)
Brugada syndrome - Report of the second consensus conference - Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association
C Antzelevitch et al.
CIRCULATION (2005)
Short QT syndrome: mechanisms, diagnosis and treatment
P Bjerregaard et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2005)
Cardiac channelopathies: it's in the genes
MJ Ackerman
NATURE MEDICINE (2004)
Short QT syndrome:: Pharmacological treatment
F Gaita et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome
PJ Schwartz et al.
CIRCULATION (2004)
Low birth weight and increased sympathetic activity
G Weitz et al.
CIRCULATION (2004)
Association of long QT syndrome loci and cardiac events among patients treated with β-blockers
SG Priori et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Mutation in the KCNQ1 gene leading to the short QT-interval syndrome
C Bellocq et al.
CIRCULATION (2004)
Brugada syndrome - An under-recognized electrical disease in patients with sudden cardiac death
JM Juang et al.
CARDIOLOGY (2004)
Risk stratification in the long-QT syndrome
SG Priori et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia
SG Priori et al.
CIRCULATION (2002)
A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel
H Lahat et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Share Paper
